{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:33:00Z","timestamp":1740144780661,"version":"3.37.3"},"reference-count":4,"publisher":"American Diabetes Association","issue":"10","license":[{"start":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T00:00:00Z","timestamp":1600646400000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/www.diabetesjournals.org\/content\/license"}],"funder":[{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["K08HS023898"],"award-info":[{"award-number":["K08HS023898"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","award":["CER-2017C3-9230"],"award-info":[{"award-number":["CER-2017C3-9230"]}],"id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,10,1]]},"DOI":"10.2337\/dci20-0036","type":"journal-article","created":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T17:20:01Z","timestamp":1611854401000},"page":"e159-e159","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":0,"title":["Response to Comment on Flory et al. Reports of Lactic Acidosis Attributed to Metformin, 2015\u20132018. Diabetes Care 2020;43:244\u2013246"],"prefix":"10.2337","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0259-969X","authenticated-orcid":false,"given":"James H.","family":"Flory","sequence":"first","affiliation":[{"name":"Memorial Sloan-Kettering Cancer Center, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0259-969X","authenticated-orcid":false,"given":"Sean","family":"Hennessy","sequence":"additional","affiliation":[{"name":"University of Pennsylvania Perelman School of Medicine, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6998-6811","authenticated-orcid":false,"given":"Clifford J.","family":"Bailey","sequence":"additional","affiliation":[{"name":"School of Life and Health Sciences, Aston University, Birmingham, U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1254-6636","authenticated-orcid":false,"given":"Silvio E.","family":"Inzucchi","sequence":"additional","affiliation":[{"name":"Yale School of Medicine, New Haven, CT"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1167","published-online":{"date-parts":[[2020,9,11]]},"reference":[{"key":"2022031223545081100_B1","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.2337\/dc20-0993","article-title":"Comment on Flory et al. Reports of lactic acidosis attributed to metformin, 2015\u20132018. Diabetes Care 2020;43:244\u2013246 (Letter)","volume":"43","author":"Brand","year":"2020","journal-title":"Diabetes Care"},{"key":"2022031223545081100_B2","doi-asserted-by":"crossref","first-page":"244","DOI":"10.2337\/dc19-0923","article-title":"Reports of lactic acidosis attributed to metformin, 2015\u20132018","volume":"43","author":"Flory","year":"2020","journal-title":"Diabetes Care"},{"key":"2022031223545081100_B3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12882-018-0875-8","article-title":"Metformin associated lactic acidosis: a case series of 28 patients treated with sustained low-efficiency dialysis (SLED) and long-term follow-up","volume":"19","author":"Angioi","year":"2018","journal-title":"BMC Nephrol"},{"key":"2022031223545081100_B4","unstructured":"European Medicines Agency. Change management for the launch of the new EudraVigilance system. Accessed 5 May 2019. https:\/\/www.ema.europa.eu\/en\/human-regulatory\/research-development\/pharmacovigilance\/eudravigilance\/change-management-launch-new-eudravigilance-system"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/care.diabetesjournals.org\/syndication\/doi\/10.2337\/dci20-0036","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/43\/10\/e159\/630155\/dci200036.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/43\/10\/e159\/630155\/dci200036.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T03:41:42Z","timestamp":1647142902000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/43\/10\/e159\/35891\/Response-to-Comment-on-Flory-et-al-Reports-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,11]]},"references-count":4,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,9,11]]},"published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dci20-0036","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"type":"print","value":"0149-5992"},{"type":"electronic","value":"1935-5548"}],"subject":[],"published":{"date-parts":[[2020,9,11]]}}}